LSE Capital approves joint venture with LABLINK Enterprises to bid for Sindh project

LSE Capital Limited (LSECL) has cleared a proposed partnership with LABLINK Enterprises so the two can seek qualification and submit a bid for a Sindh project. Profit by Pakistan Today reported that the board approved the move through a resolution circulated among its members, with the company notifying the Pakistan Stock Exchange on Thursday.

LABLINK is a registered sole proprietorship that imports and supplies medical, healthcare and surgical equipment, including products from NIPRO and Baxter. The disclosure gives no details on the project’s purpose or estimated cost, the venture’s financial arrangement, or how duties would be divided. It also does not say whether the parties have qualified or placed a bid, so the approved step is participation in the process rather than a confirmed award.